From: Italian guidelines for primary headaches: 2012 revised version
Drug | Daily dosage (mg) | Level of evidence | Scientific strength of evidencea | Clinical effectiveness | Adverse events | No. of cases | References |
---|---|---|---|---|---|---|---|
Indomethacin | 25–50 | C | 0/+ | + | – | 1 | [322] |
Indomethacin | 75 | C | 0/+ | +++ | Occasional, not severe | 8 | |
Indomethacin | 150 | C | 0/+ | +++ | – | 2 | |
Indomethacin | 200–225 | C | 0/+ | ++ | Occasional, not severe | 3 | |
Verapamil | 480 | C | 0/+ | ? | – | 1 | [333] |
Piroxicam-β-cyclodextrine | 20–40 | C | 0/+ | ++ | – | 6 | [334] |
Rofecoxib | 25 | C | 0/+ | +++ | – | 1 | [317] |
Rofecoxib | 50 | C | 0/+ | +++ | Occasional, not severe | 2 | |
Celecoxib | 400 | C | 0/+ | +++ | – | 1 | [319] |
Verapamil | 240–320 | C | 0/+ | ++ | – | 10 | [320] |